Concepedia

Publication | Open Access

Ganetespib in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung Cancer

11

Citations

33

References

2019

Year

Abstract

Ganetespib might be a promising therapeutic option for the treatment of patients with EGFR-TKI-resistant NSCLC.

References

YearCitations

Page 1